ArticleHepatology international2013

The virological response in Koreans infected with HCV genotype 1 did not differ between groups treated with a full dose or reduced dose (≥80 % full dose) of peginterferon alfa-2a: a prospective randomized multicenter trial.

Jung Hyun Kwon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.